Location History:
- Rotterdam, CH (2016)
- Nussbaumen, CH (2019)
Company Filing History:
Years Active: 2016-2019
Title: **Cristina Magdalena Mueller: A Trailblazer in Radiopharmaceutical Innovation**
Introduction
Cristina Magdalena Mueller, a prominent inventor based in Nussbaumen, Switzerland, has made significant contributions to the field of radiopharmaceuticals through her innovative patents. With a total of two patents to her name, her work primarily focuses on advanced methods for targeting and diagnosing cancer and autoimmune diseases through folate and antifolate analogues.
Latest Patents
Cristina's latest patents include the groundbreaking invention titled “18F-labelled folate/antifolate analogues.” This invention aims to develop novel fluorine-18-labelled folate/antifolate analog radiopharmaceuticals. Specifically, it involves the replacement of the phenyl group in folate structures with a fluorine-heterocycle, enhancing their application in diagnosing cells that express a folate receptor and monitoring various diseases.
The second recent patent, “Method for cell-specific targeting,” outlines a strategy for the selective delivery of diagnostic or therapeutic agents to cells that express folate receptors. This method involves the simultaneous or sequential administration of an antifolate alongside a folate- or pteroate-conjugate, which is designed to improve the effectiveness of targeted therapy.
Career Highlights
Cristina has garnered experience at reputable companies such as Merck & Cie, where she has applied her expertise in radiopharmaceutical development. Her work at these institutions has enabled her to spearhead innovative projects that leverage her knowledge of folate-targeting mechanisms.
Collaborations
Throughout her career, Cristina has collaborated with esteemed professionals, including Roger Schibli and Rudolf Moser. These partnerships have contributed to her research and development efforts, facilitating advancements in the medical applications of her inventions.
Conclusion
Cristina Magdalena Mueller's innovative contributions in the field of radiopharmaceuticals are paving the way for improved diagnostic and therapeutic strategies in medicine. Her dedication to developing new methodologies demonstrates the vital role of inventors in advancing healthcare technologies.